Niagen Bioscience (NAGE) Non-Current Assets (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Non-Current Assets data on file, last reported at $9.2 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $9.2 million, up 79.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.2 million (up 53.0% YoY), and the FY2025 annual result was $9.6 million, up 129.89% from the prior year.
• Non-Current Assets slipped to $9.2 million in Q1 2026 per NAGE's latest filing, from $9.6 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $9.6 million in Q4 2025 and troughed at $4.2 million in Q4 2024.
• A 5-year average of $6.4 million and a median of $6.3 million in 2023 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets sank 30.37% in 2024, then jumped 129.89% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $7.5 million in 2022, then fell by 27.5% to $5.4 million in 2023, then fell by 23.09% to $4.2 million in 2024, then surged by 129.89% to $9.6 million in 2025, then declined by 4.08% to $9.2 million in 2026.
• Business Quant data shows NAGE's Non-Current Assets at $9.2 million in Q1 2026, $9.6 million in Q4 2025, and $4.5 million in Q3 2025.